Associate Professor Mustafa Khasraw is a Clinical Lead at the CTC with a leading role in several clinical and translational programs. He is also a practicing medical oncologist at Royal North Shore Hospital in Sydney.

Mustafa has worked in several countries and received his MD from the University of Groningen in the Netherlands and he has worked as an oncology fellow at Addenbrooke’s hospital in Cambridge UK (2005-2007). He trained as a medical oncologist at Royal North Shore Hospital in Sydney (2007-2010) and completed a subsequent neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York (2010-2011) prior to his return to Australia.

Mustafa has been working at the CTC since 2012 and he leads an extensive clinical trials team with significant laboratory collaborations and a focus on targeted therapies and immuno-oncology in glioblastoma (GBM) and other rare and underserved cancers. He is lead principal investigator on phase I, II and III clinical trials for a number of ongoing academic and pharmaceutical multi-centre clinical studies with a special interest in innovative trial design. Mustafa holds a Medical Research Future Fund Next Generation Clinical Trials Fellowship.

Publications

View Mustafa's publications.